Skip to main content
. 2020 Jun 12;105(4):549–554. doi: 10.1136/bjophthalmol-2020-315836

Figure 1.

Figure 1

ConsolidatedStandards of Reporting Trials flow diagram for the entire patient population. anti-VEGF, anti-vascular endothelial growth factor; BRVO, branchretinal vein occlusion; DMO, diabetic macular oedema; PDR, proliferativediabetic retinopathy; VA, visual acuity.